Cargando…

E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6

BACKGROUND: Some studties reported that the polymorphism of TM6SF2 gene E167K affects the occurrence and the progression of hepatocytes carcinoma (hepatocellular, HCC). In oeder to investigate the effects of the polymorphism of TM6SF2 gene E167K in the pathogenesis of HCC, we explored its influence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Shuixian, Lu, Linlin, Miao, Yingxia, Jin, Wenwen, Li, Changfei, Xin, Yongning, Xuan, Shiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390375/ https://www.ncbi.nlm.nih.gov/pubmed/28407767 http://dx.doi.org/10.1186/s12944-017-0468-8

Ejemplares similares

TM6SF2 E167K Variant Overexpression Promotes Expression of Inflammatory Cytokines in the HCC Cell Line HEPA 1-6
por: Du, Shuixian, et al.
Publicado: (2019)

The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism
por: Chen, Lizhen, et al.
Publicado: (2017)

The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant
por: Zhang, Xiaoyu, et al.
Publicado: (2018)

TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease
por: Chen, Li-Zhen, et al.
Publicado: (2015)

Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
por: Borén, Jan, et al.
Publicado: (2020)

Type 2 diabetes sex-specific effects associated with E167K coding variant in TM6SF2
por: Fan, Yanbo, et al.
Publicado: (2021)

Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population
por: Li, Yuan, et al.
Publicado: (2019)

The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis
por: Liu, Zhengtao, et al.
Publicado: (2017)

Meta-analysis of the influence of TM6SF2 E167K variant on Plasma Concentration of Aminotransferases across different Populations and Diverse Liver Phenotypes
por: Sookoian, Silvia, et al.
Publicado: (2016)

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022)

The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
por: Prill, Sebastian, et al.
Publicado: (2019)

Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease
por: Wu, Jian-Ting, et al.
Publicado: (2020)

Effect of Genistein on Apoptosis and Proliferation of Hepatocellular Carcinoma Hepa1-6 Cell Line
por: Sanaei, Masumeh, et al.
Publicado: (2018)

Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis
por: Tang, Shan, et al.
Publicado: (2019)

The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients
por: Raia, Gamal Y. S., et al.
Publicado: (2022)

TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
por: Basyte-Bacevice, Viktorija, et al.
Publicado: (2019)

Mechanism of inhibiting proliferation of hepatocellular carcinoma Hepa1-6 cells by embryonic stem cell-conditioned medium
por: Li, Longqin, et al.
Publicado: (2020)

Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line
por: Pant, Asmita, et al.
Publicado: (2021)

TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6
por: Hou, Sicong, et al.
Publicado: (2022)

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC
por: Kruk, Beata, et al.
Publicado: (2018)

PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
por: Lisboa, Quelson Coelho, et al.
Publicado: (2020)

TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
por: Luo, Fei, et al.
Publicado: (2021)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model
por: Kimura, Takayuki, et al.
Publicado: (2018)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011)

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity
por: Ahn, Hye-Mi, et al.
Publicado: (2017)

TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease
por: Sanchez-Pulido, Luis, et al.
Publicado: (2014)

Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
por: Luo, Fei, et al.
Publicado: (2021)

Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2
por: Pott, Janne, et al.
Publicado: (2021)

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype
por: Sagnelli, Caterina, et al.
Publicado: (2016)

N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
por: Song, Haeng Eun, et al.
Publicado: (2021)

Liver-specific deletion of Mttp versus Tm6sf2 reveals distinct defects in stepwise VLDL assembly
por: Newberry, Elizabeth P., et al.
Publicado: (2021)

Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments
por: Shin, Sung-Won, et al.
Publicado: (2021)

Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis
por: Ma, Xuefeng, et al.
Publicado: (2021)

m(6)Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation
por: Zhuo, Wei, et al.
Publicado: (2022)

S7-2 From HEPA to sustainable HEPA?
por: Abu-Omar, Karim, et al.
Publicado: (2023)

TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth
por: Singhal, Megha, et al.
Publicado: (2019)

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
por: Liu, Yang-Lin, et al.
Publicado: (2014)

NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
por: Sliz, Eeva, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2ck7p801l58cpcn7tg5ho7b1da